Search Results - "Bode, Bruce W"

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System by Bailey, Timothy, Bode, Bruce W, Christiansen, Mark P, Klaff, Leslie J, Alva, Shridhara

“…The purpose of the study was to evaluate the performance and usability of the FreeStyle(®) Libre™ Flash glucose monitoring system (Abbott Diabetes Care,…”
Get more information

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia by Bergenstal, Richard M, Klonoff, David C, Garg, Satish K, Bode, Bruce W, Meredith, Melissa, Slover, Robert H, Ahmann, Andrew J, Welsh, John B, Lee, Scott W, Kaufman, Francine R

“…In this study involving patients with type 1 diabetes, sensor-augmented insulin-pump therapy plus automated insulin suspension when glucose dropped below 70 mg…”
Get full text

Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1) by Russell-Jones, David, Bode, Bruce W, De Block, Christophe, Franek, Edward, Heller, Simon R, Mathieu, Chantal, Philis-Tsimikas, Athena, Rose, Ludger, Woo, Vincent C, Østerskov, Anne Birk, Graungaard, Tina, Bergenstal, Richard M

“…This multicenter, treat-to-target, phase 3 trial evaluated the efficacy and safety of fast-acting insulin aspart (faster aspart) versus conventional insulin…”
Get full text

New Insulin Delivery Recommendations by Frid, Anders H., MD, Kreugel, Gillian, DSN, Grassi, Giorgio, MD, Halimi, Serge, MD, Hicks, Debbie, DSN, Hirsch, Laurence J., MD, Smith, Mike J., DSN, Wellhoener, Regine, MD, Bode, Bruce W., MD, Hirsch, Irl B., MD, Kalra, Sanjay, MD, Ji, Linong, MD, Strauss, Kenneth W., MD

“…Abstract Many primary care professionals manage injection or infusion therapies in patients with diabetes. Few published guidelines have been available to help…”
Get full text

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes by Sands, Arthur T, Zambrowicz, Brian P, Rosenstock, Julio, Lapuerta, Pablo, Bode, Bruce W, Garg, Satish K, Buse, John B, Banks, Phillip, Heptulla, Rubina, Rendell, Marc, Cefalu, William T, Strumph, Paul

“…To assess the safety and efficacy of dual sodium-glucose cotransporter (SGLT) 1 and SGLT2 inhibition with sotagliflozin as adjunct therapy to insulin in type 1…”
Get full text

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial by Bowering, Keith, Case, Christopher, Harvey, John, Reeves, Michael, Sampson, Michael, Strzinek, Robert, Bretler, Ditte-Marie, Bang, Rikke Beck, Bode, Bruce W

“…This multicenter, double-blind, treat-to-target, phase 3 trial evaluated the efficacy and RESEARCH DESIGN AND METHODS: The primary end point was HbA change…”
Get full text

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry by Wong, Jenise C, Foster, Nicole C, Maahs, David M, Raghinaru, Dan, Bergenstal, Richard M, Ahmann, Andrew J, Peters, Anne L, Bode, Bruce W, Aleppo, Grazia, Hirsch, Irl B, Kleis, Lora, Chase, H Peter, DuBose, Stephanie N, Miller, Kellee M, Beck, Roy W, Adi, Saleh

“…To assess the frequency of continuous glucose monitoring (CGM) device use, factors associated with its use, and the relationship of CGM with diabetes outcomes…”
Get full text

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT by Bailey, Timothy S, Grunberger, George, Bode, Bruce W, Handelsman, Yehuda, Hirsch, Irl B, Jovanovič, Lois, Roberts, Victor Lawrence, Rodbard, David, Tamborlane, William V, Walsh, John

“…This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were…”
Get more information

Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trial by Buse, John B, Bode, Bruce W, Mertens, Ann, Cho, Young Min, Christiansen, Erik, Hertz, Christin L, Nielsen, Morten A, Pieber, Thomas R

“…IntroductionThe PIONEER 7 trial demonstrated superior glycemic control and weight loss with once-daily oral semaglutide with flexible dose adjustment versus…”
Get full text

Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio by Davidson, Paul C, Hebblewhite, Harry R, Steed, Robert D, Bode, Bruce W

“…To analyze and compare the underlying mathematical models for basal-bolus insulin-dosing guidelines in patients with type 1 diabetes in a retrospective…”
Get more information

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII by Hirsch, Irl B, Bode, Bruce W, Garg, Satish, Lane, Wendy S, Sussman, Allen, Hu, Peter, Santiago, Olga M, Kolaczynski, Jerzy W

“…OBJECTIVE:--Multiple daily injection (MDI) therapy of bolus insulin aspart and basal insulin glargine was compared with continuous subcutaneous insulin…”
Get full text

Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study by Grunberger, George, Rosenfeld, Cheryl R., Bode, Bruce W., Abbott, Scott D., Nikkel, Carla, Shi, Leon, Strange, Poul

“…Background V-Go is a wearable, patch-like, 24-h insulin delivery device that delivers both a continuous preset basal rate and on-demand bolus dosing. The aim…”
Get full text

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes by Bergenstal, Richard M, Garg, Satish, Weinzimer, Stuart A, Buckingham, Bruce A, Bode, Bruce W, Tamborlane, William V, Kaufman, Francine R

Get full text

Continuous and Intermittent Glucose Monitoring in 2022 by Dovc, Klemen, Bode, Bruce W, Battelino, Tadej

Get more information

Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: Insulin pump therapy versus multiple daily injections by Bode, Bruce W., MD

“…Abstract Background: Replicating endogenous insulin production is the goal of treatment for diabetes mellitus (DM) and is necessary to minimize the risk of…”
Get full text

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial by Pratley, Richard E, Kanapka, Lauren G, Rickels, Michael R, Ahmann, Andrew, Aleppo, Grazia, Beck, Roy, Bhargava, Anuj, Bode, Bruce W, Carlson, Anders, Chaytor, Naomi S, Fox, D Steven, Goland, Robin, Hirsch, Irl B, Kruger, Davida, Kudva, Yogish C, Levy, Carol, McGill, Janet B, Peters, Anne, Philipson, Louis, Philis-Tsimikas, Athena, Pop-Busui, Rodica, Shah, Viral N, Thompson, Michael, Vendrame, Francesco, Verdejo, Alandra, Weinstock, Ruth S, Young, Laura, Miller, Kellee M

“…Continuous glucose monitoring (CGM) provides real-time assessment of glucose levels and may be beneficial in reducing hypoglycemia in older adults with type 1…”
Get full text

Continuous and Intermittent Glucose Monitoring in 2021 by Dovc, Klemen, Bode, Bruce W, Battelino, Tadej

Get more information

Defining the Importance of Daily Glycemic Control and Implications for Type 2 Diabetes Management by Bode, Bruce W.

“…Glycemic control remains an elusive goal for most patients with type 2 diabetes. Questions concerning glucose targets that have emerged from recent outcomes…”
Get full text

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors by Danne, Thomas, Garg, Satish, Peters, Anne L, Buse, John B, Mathieu, Chantal, Pettus, Jeremy H, Alexander, Charles M, Battelino, Tadej, Ampudia-Blasco, F Javier, Bode, Bruce W, Cariou, Bertrand, Close, Kelly L, Dandona, Paresh, Dutta, Sanjoy, Ferrannini, Ele, Fourlanos, Spiros, Grunberger, George, Heller, Simon R, Henry, Robert R, Kurian, Martin J, Kushner, Jake A, Oron, Tal, Parkin, Christopher G, Pieber, Thomas R, Rodbard, Helena W, Schatz, Desmond, Skyler, Jay S, Tamborlane, William V, Yokote, Koutaro, Phillip, Moshe

“…Sodium-glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic…”
Get full text

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes by Brown, Sue A, Forlenza, Gregory P, Bode, Bruce W, Pinsker, Jordan E, Levy, Carol J, Criego, Amy B, Hansen, David W, Hirsch, Irl B, Carlson, Anders L, Bergenstal, Richard M, Sherr, Jennifer L, Mehta, Sanjeev N, Laffel, Lori M, Shah, Viral N, Bhargava, Anuj, Weinstock, Ruth S, MacLeish, Sarah A, DeSalvo, Daniel J, Jones, Thomas C, Aleppo, Grazia, Buckingham, Bruce A, Ly, Trang T

“…Advances in diabetes technology have transformed the treatment paradigm for type 1 diabetes, yet the burden of disease is significant. We report on a pivotal…”
Get full text